Skip to main content

Key Product Details

Species Reactivity

Human, Mouse

Applications

Western Blot

Label

DyLight 650 (Excitation = 652 nm, Emission = 672 nm)

Antibody Source

Polyclonal Goat IgG

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

E. coli-derived recombinant human GLRX1
Met1-Gln106
Accession # P35754

Specificity

Detects human and mouse GLRX1 in Western blots.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Applications for Glutaredoxin 1/GLRX1 Antibody [DyLight 650]

Application
Recommended Usage

Western Blot

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Formulation

50mM Sodium Borate

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: Glutaredoxin 1/GLRX1

Glutaredoxins (e.g., GLRX; MIM 600443) are a family of glutathione-dependent hydrogen donors that participate in avariety of cellular redox reactions.(supplied by OMIM)

Alternate Names

GLRX, Thioltransferase

Gene Symbol

GLRX

Additional Glutaredoxin 1/GLRX1 Products

Product Documents for Glutaredoxin 1/GLRX1 Antibody [DyLight 650]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Glutaredoxin 1/GLRX1 Antibody [DyLight 650]



DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...